Conventional coagulation tests, such as the prothrombin time (PT, and the PT‐derived International Normalized Ratio, INR) and the activated partial thromboplastin time (aPTT), do not reflect coagulation status in patients with liver disease. The gene discussed is F2; the disease is liver disorder.